Virtua is one of only 1,400 facilities in the United States that is accredited by the Commission on Cancer (COC) of the American College of Surgeons. Accreditation is granted to facilities that voluntarily commit to providing the best in cancer diagnosis and treatment. Receiving care at a COC-accredited program, such as Virtua’s, ensures each patient will receive:
- Comprehensive care
- A team approach
- Access to prevention and early treatment programs
- Information about clinical trials; a cancer registry that provides life-long patient follow-up and quality of care close to home
In addition to this accreditation Virtua has received the COC “Outstanding Achievement Award”.
Virtua collaborates with Fox Chase Cancer Center in Philadelphia to provide preventative, diagnostic and treatment services through the Virtua Fox Chase Cancer Program.The Virtua Fox Chase Cancer Program consists of an Oncology Panel of doctors that has been recognized by the Fox Chase Cancer Center and must meet Fox Chase's high standards. The Oncology Panel is board certified, practice medicine in a prescribed way, participate in quality assurance audits and attend continuing education programs.
The Virtua Fox Chase Cancer Program's highly integrated team of oncology specialists is dedicated to providing individualized, state-of-the-art treatment – and personalized supportive care – to patients with many types of cancer.
Each patient receives an individualized treatment plan, incorporating the most advanced diagnostic and treatment procedures, such as:
- Minimally invasive biopsies and surgical treatments
-
Radiation therapy
- Digital mammography
- Medical oncology – including state-of-the-art chemotherapy agents and techniques
- Biologic therapy (immunotherapy) such as monoclonal antibodies, vaccines and gene therapy
- International, national and regional clinical trials for almost every type of cancer
The program delivers the following clinical services:
In addition, cancer specialists attend multidisciplinary cancer conferences. Surgeons, medical oncologists, radiation oncologists, radiologists, pathologists, cancer genetic specialists, nurse navigators, clinical oncology social workers, research staff, and oncology nurses specializing in cancer care attend these multidisciplinary meetings, which are forums to discuss treatment options and planning for newly diagnosed cancer patients.